127 related articles for article (PubMed ID: 25815140)
1. Identification of 8-aminoadenosine derivatives as a new class of human concentrative nucleoside transporter 2 inhibitors.
Tatani K; Hiratochi M; Nonaka Y; Isaji M; Shuto S
ACS Med Chem Lett; 2015 Mar; 6(3):244-8. PubMed ID: 25815140
[TBL] [Abstract][Full Text] [Related]
2. Identification of Adenine and Benzimidazole Nucleosides as Potent Human Concentrative Nucleoside Transporter 2 Inhibitors: Potential Treatment for Hyperuricemia and Gout.
Tatani K; Hiratochi M; Kikuchi N; Kuramochi Y; Watanabe S; Yamauchi Y; Itoh F; Isaji M; Shuto S
J Med Chem; 2016 Apr; 59(8):3719-31. PubMed ID: 27007871
[TBL] [Abstract][Full Text] [Related]
3. Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells.
Lang TT; Selner M; Young JD; Cass CE
Mol Pharmacol; 2001 Nov; 60(5):1143-52. PubMed ID: 11641443
[TBL] [Abstract][Full Text] [Related]
4. Homology Modeling of Human Concentrative Nucleoside Transporters (hCNTs) and Validation by Virtual Screening and Experimental Testing to Identify Novel hCNT1 Inhibitors.
Kumar Deokar H; Barch HP; Buolamwini JK
Drug Des; 2017 Mar; 6(1):. PubMed ID: 29167753
[TBL] [Abstract][Full Text] [Related]
5. Molecular requirements of the human nucleoside transporters hCNT1, hCNT2, and hENT1.
Chang C; Swaan PW; Ngo LY; Lum PY; Patil SD; Unadkat JD
Mol Pharmacol; 2004 Mar; 65(3):558-70. PubMed ID: 14978234
[TBL] [Abstract][Full Text] [Related]
6. Ribavirin uptake into human hepatocyte HHL5 cells is enhanced by interferon-α via up-regulation of the human concentrative nucleoside transporter (hCNT2).
Pinilla-Macua I; Fernández-Calotti P; Pérez-Del-Pulgar S; Pastor-Anglada M
Mol Pharm; 2014 Sep; 11(9):3223-30. PubMed ID: 24957263
[TBL] [Abstract][Full Text] [Related]
7. Interactions with selected drug renal transporters and transporter-mediated cytotoxicity in antiviral agents from the group of acyclic nucleoside phosphonates.
Mandíková J; Volková M; Pávek P; Česnek M; Janeba Z; Kubíček V; Trejtnar F
Toxicology; 2013 Sep; 311(3):135-46. PubMed ID: 23856525
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine.
Ritzel MW; Yao SY; Ng AM; Mackey JR; Cass CE; Young JD
Mol Membr Biol; 1998; 15(4):203-11. PubMed ID: 10087507
[TBL] [Abstract][Full Text] [Related]
9. Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line.
Lang TT; Young JD; Cass CE
Mol Pharmacol; 2004 Apr; 65(4):925-33. PubMed ID: 15044622
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
11. Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum.
Shin HC; Landowski CP; Sun D; Vig BS; Kim I; Mittal S; Lane M; Rosania G; Drach JC; Amidon GL
Biochem Biophys Res Commun; 2003 Aug; 307(3):696-703. PubMed ID: 12893280
[TBL] [Abstract][Full Text] [Related]
12. Cation coupling properties of human concentrative nucleoside transporters hCNT1, hCNT2 and hCNT3.
Smith KM; Slugoski MD; Cass CE; Baldwin SA; Karpinski E; Young JD
Mol Membr Biol; 2007; 24(1):53-64. PubMed ID: 17453413
[TBL] [Abstract][Full Text] [Related]
13. Identification of functional promoter haplotypes of human concentrative nucleoside transporter 2, hCNT2 (SLC28A2).
Li L; Koo SH; Hong IH; Lee EJ
Drug Metab Pharmacokinet; 2009; 24(2):161-6. PubMed ID: 19430172
[TBL] [Abstract][Full Text] [Related]
14. Interaction of intestinal nucleoside transporter hCNT2 with amino acid ester prodrugs of floxuridine and 2-bromo-5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole.
Shin HC; Kim JS; Vig BS; Song X; Drach JC; Amidon GL
Biol Pharm Bull; 2006 Feb; 29(2):247-52. PubMed ID: 16462026
[TBL] [Abstract][Full Text] [Related]
15. Hypouricemic effects of novel concentrative nucleoside transporter 2 inhibitors through suppressing intestinal absorption of purine nucleosides.
Hiratochi M; Tatani K; Shimizu K; Kuramochi Y; Kikuchi N; Kamada N; Itoh F; Isaji M
Eur J Pharmacol; 2012 Sep; 690(1-3):183-91. PubMed ID: 22709993
[TBL] [Abstract][Full Text] [Related]
16. Recent molecular advances in studies of the concentrative Na+-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib).
Ritzel MW; Ng AM; Yao SY; Graham K; Loewen SK; Smith KM; Hyde RJ; Karpinski E; Cass CE; Baldwin SA; Young JD
Mol Membr Biol; 2001; 18(1):65-72. PubMed ID: 11396613
[TBL] [Abstract][Full Text] [Related]
17. SLC28 genes and concentrative nucleoside transporter (CNT) proteins.
Pastor-Anglada M; Cano-Soldado P; Errasti-Murugarren E; Casado FJ
Xenobiotica; 2008 Jul; 38(7-8):972-94. PubMed ID: 18668436
[TBL] [Abstract][Full Text] [Related]
18. Effect of dietary purines on the pharmacokinetics of orally administered ribavirin.
Li L; Koo SH; Limenta LM; Han L; Hashim KB; Quek HH; Lee EJ
J Clin Pharmacol; 2009 Jun; 49(6):661-7. PubMed ID: 19369574
[TBL] [Abstract][Full Text] [Related]
19. Identification and Characterization of a Secondary Sodium-Binding Site and the Main Selectivity Determinants in the Human Concentrative Nucleoside Transporter 3.
Arimany-Nardi C; Claudio-Montero A; Viel-Oliva A; Schmidtke P; Estarellas C; Barril X; Bidon-Chanal A; Pastor-Anglada M
Mol Pharm; 2017 Jun; 14(6):1980-1987. PubMed ID: 28441873
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Flexible Naphthyltriazolylmethane-based Thioacetic Acids as Highly Active Uric Acid Transporter 1 (URAT1) Inhibitors for the Treatment of Hyperuricemia of Gout.
Zhang X; Wu J; Liu W; Liu Y; Xie Y; Shang Q; Zhou Z; Xu W; Tang L; Wang J; Zhao G
Med Chem; 2017; 13(3):260-281. PubMed ID: 27633583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
